Three out of four patients with new symptoms suggestive of CAD underwent noninvasive testing during their first examination, according to results of a real-world, retrospective, single-center study.

CLEVELAND, OH — The age/sex/gene-expression score (ASGES) test known as Corus CAD (CardioDx) appears easy to incorporate and effective in excluding obstructive coronary artery disease (CAD) in ...

It's been a difficult year for CardioDx, but there may be light at the end of the tunnel: In a new study, researchers found that the company's genetic test for coronary artery disease could help ...

A low score on a blood test that evaluates age, sex and gene expression may help to rule out the presence of obstructive CAD in symptomatic women, according to results published in Menopause. In an ...

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced online publication of a study in the The paper, titled “A Gender Specific Blood-Based Gene Expression ...

Scientists at Sanford Burnham Prebys Medical Discovery Institute and the Centro de Biología Molecular Severo Ochoa in Spain have created a test that determines which children with CAD deficiency - a ...